Get the Stockscreener App
2.80
2.78%
-0.08
After Hours:
2.84
0.04
+1.43%
Nrx Pharmaceuticals Inc stock is traded at $2.80, with a volume of 481.65K.
It is down -2.78% in the last 24 hours and up +17.15% over the past month.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$2.88
Open:
$2.89
24h Volume:
481.65K
Relative Volume:
1.49
Market Cap:
$55.47M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-0.70
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
+1.82%
1M Performance:
+17.15%
6M Performance:
+31.46%
1Y Performance:
+55.56%
1-Day Range:
$2.73
$2.8967
1-Week Range:
$2.73
$3.1894
52-Week Range:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
Nrx Pharmaceuticals Inc
Sector
Industry
Phone
484-254-6134
Address
1201 ORANGE STREET, WILMINGTON
Compare NRXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.80 | 70.60M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | H.C. Wainwright | Buy |
| Apr-02-25 | Initiated | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Stock (NRXP) Latest News
NRX Pharmaceuticals Raises $8.8 Million in Stock Offering - MSN
NRX Pharmaceuticals Completes Acquisition of Dura Medical - TipRanks
Research Analysts Set Expectations for NRXP Q3 Earnings - MarketBeat
Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - GlobeNewswire
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Buy Rating from D. Boral Capital - MarketBeat
HC Wainwright Begins Coverage on NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat
NRx Pharmaceuticals (NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical - NewMediaWire
Is NRx Pharmaceuticals Inc. a potential multi bagger2025 Trading Volume Trends & Free Verified High Yield Trade Plans - Lancaster City Council
$40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy | FinancialContent - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical - TipRanks
$40 Price Target in New H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
How do insiders feel about NRx Pharmaceuticals Inc. Equity Warrant - Lancaster City Council
NRX Pharmaceuticals at H.C. Wainwright: Pioneering Neuropsychiatric Care By Investing.com - Investing.com Canada
Can NRx Pharmaceuticals Inc. stock outperform in a bear marketQuarterly Trade Summary & Consistent Growth Equity Picks - 뉴스영
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics - The Manila Times
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. - GlobeNewswire
Targeting 10,000 Patients by 2026: HOPE Therapeutics Acquires Dura Medical in Florida Mental Health Expansion - Stock Titan
Can NRx Pharmaceuticals Inc. Equity Warrant disrupt its industryEntry Point & AI Powered Buy and Sell Recommendations - beatles.ru
NRx Pharmaceuticals CEO to Speak at H.C. Wainwright Global Investment Conference - MSN
Can NRx Pharmaceuticals Inc. ride the EV waveJuly 2025 Drop Watch & Verified High Yield Trade Plans - classian.co.kr
Published on: 2025-09-06 12:52:39 - Newser
Can technical indicators confirm NRx Pharmaceuticals Inc.’s reversalJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
NRx Pharmaceuticals Inc.’s volatility index tracking explainedTrade Performance Summary & Long-Term Capital Growth Ideas - Newser
Is NRx Pharmaceuticals Inc. Equity Warrant’s growth already priced inWeekly Gains Report & Daily Risk Controlled Trade Plans - خودرو بانک
Is NRx Pharmaceuticals Inc. Equity Warrant stock risky to hold nowCPI Data & Pattern Based Trade Signal System - خودرو بانک
What earnings revisions data tells us about NRx Pharmaceuticals Inc.Oil Prices & Target Return Focused Stock Picks - Newser
Has NRx Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
What is NRx Pharmaceuticals Inc.’s book value per shareEarnings Growth Summary & Weekly Stock Performance Updates - خودرو بانک
What’s the beta of NRx Pharmaceuticals Inc. stockStop Loss & Risk Managed Investment Strategies - خودرو بانک
How to use Fibonacci retracement on NRx Pharmaceuticals Inc.2025 Market WrapUp & Long-Term Capital Growth Strategies - Newser
Using Ichimoku Cloud for NRx Pharmaceuticals Inc. Equity Warrant technicalsIndex Update & Weekly Breakout Stock Alerts - Newser
NRx Pharmaceuticals Inc. stock momentum explainedMarket Volume Report & Weekly Chart Analysis and Trade Guides - Newser
NRx Pharmaceuticals Inc. Matches Institutional Buying FilterPortfolio Performance Summary & High Return Stock Watch Alerts - beatles.ru
Can momentum traders help lift NRx Pharmaceuticals Inc.July 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
What’s next for NRx Pharmaceuticals Inc. Equity Warrant stock priceMarket Performance Report & Stock Portfolio Risk Control - Newser
Is NRx Pharmaceuticals Inc. Equity Warrant trending in predictive chart modelsJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - Newser
Aug Movers: Will NRx Pharmaceuticals Inc. Equity Warrant face regulatory challengesJuly 2025 Trends & Weekly Consistent Profit Watchlists - خودرو بانک
Is NRx Pharmaceuticals Inc. Equity Warrant stock a value trapQuarterly Portfolio Report & AI Forecast Swing Trade Picks - خودرو بانک
What’s the profit margin of NRx Pharmaceuticals Inc. Equity Warrant2025 Top Gainers & Advanced Swing Trade Entry Alerts - خودرو بانک
Can momentum traders help lift NRx Pharmaceuticals Inc. Equity WarrantIndex Update & Weekly High Return Stock Forecasts - Newser
Published on: 2025-09-05 06:08:53 - Newser
How hedge fund analytics apply to NRx Pharmaceuticals Inc. stockWeekly Gains Report & Capital Efficient Trade Techniques - Newser
Real time social sentiment graph for NRx Pharmaceuticals Inc. Equity WarrantMarket Movement Recap & High Accuracy Swing Entry Alerts - Newser
Can trapped investors hope for a rebound in NRx Pharmaceuticals Inc.2025 Performance Recap & Real-Time Buy Signal Alerts - Newser
Momentum divergence signals in NRx Pharmaceuticals Inc. Equity Warrant chartJuly 2025 Price Swings & Advanced Technical Analysis Signals - Newser
Applying sector rotation models to NRx Pharmaceuticals Inc.Quarterly Earnings Report & Technical Pattern Recognition Alerts - Newser
What is NRx Pharmaceuticals Inc. Equity Warrant’s valuation compared to sectorEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Sector ETF performance correlation with NRx Pharmaceuticals Inc. Equity WarrantOil Prices & Free Technical Pattern Based Buy Signals - Newser
Sentiment analysis tools applied to NRx Pharmaceuticals Inc.Trade Volume Summary & Low Drawdown Momentum Ideas - Newser
Should you avoid NRx Pharmaceuticals Inc. Equity Warrant stock right now2025 Geopolitical Influence & Verified Technical Trade Signals - خودرو بانک
NRx Pharmaceuticals (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression - The Globe and Mail
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):